Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective

Zainab Gandhi; Zeeshan Mansuri; Snehal Bansod

doi:10.1007/s42399-020-00462-2

Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective

SN Compr Clin Med. 2020;2(10):1707-1708. doi: 10.1007/s42399-020-00462-2. Epub 2020 Aug 21.

Authors

Zainab Gandhi¹, Zeeshan Mansuri², Snehal Bansod³

Affiliations

¹ Department of Infectious Diseases, University of California, San Francisco, CA USA.
² Department of Psychiatry, Texas Tech University Health Science Center at Odessa/Permian Basin, Odessa, TX USA.
³ Department of Internal Medicine, St. John's Episcopal Hospital, Far Rockaway, New York, NY USA.

Abstract

In this letter, we discuss the potential interactions of remdesivir, the newly approved Covid-19 drug with pulmonary medications. These interactions have been summarized keeping the busy clinician in mind. While remdesivir has proven to be a safe medication generally, we here have enlisted the potential interactions of remdesivir that a clinician needs to be mindful of while prescribing the medication.

Keywords: Drug interactions; Pulmonology; Remdesivir.